Global Levamisole Injection Market Growth 2026-2032
The global Levamisole Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Levamisole is a synthetic anthelmintic with activity against a broad spectrum of gastrointestinal worms and lung worms. Levamisole causes an increase of the axial muscle tone followed by paralysis of worms.
United States market for Levamisole Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Levamisole Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Levamisole Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Levamisole Injection players cover Interchemie, Hebei Hope Harmony Pharmaceutical, AdvaCare Pharma, Farmacy, Laboratorium Ofichem B.V, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Levamisole Injection Industry Forecast? looks at past sales and reviews total world Levamisole Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Levamisole Injection sales for 2026 through 2032. With Levamisole Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Levamisole Injection industry.
This Insight Report provides a comprehensive analysis of the global Levamisole Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Levamisole Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Levamisole Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Levamisole Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Levamisole Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Levamisole Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Levamisole is a synthetic anthelmintic with activity against a broad spectrum of gastrointestinal worms and lung worms. Levamisole causes an increase of the axial muscle tone followed by paralysis of worms.
United States market for Levamisole Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Levamisole Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Levamisole Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Levamisole Injection players cover Interchemie, Hebei Hope Harmony Pharmaceutical, AdvaCare Pharma, Farmacy, Laboratorium Ofichem B.V, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Levamisole Injection Industry Forecast? looks at past sales and reviews total world Levamisole Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Levamisole Injection sales for 2026 through 2032. With Levamisole Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Levamisole Injection industry.
This Insight Report provides a comprehensive analysis of the global Levamisole Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Levamisole Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Levamisole Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Levamisole Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Levamisole Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Levamisole Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 0.05
- 0.1
- Cattle
- Sheep
- Goats
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Interchemie
- Hebei Hope Harmony Pharmaceutical
- AdvaCare Pharma
- Farmacy
- Laboratorium Ofichem B.V
- Suanfarma
- Johnson & Johnson Innovative Medicines
- Xian Tian Guangyuan Biotech
- Nanjing Pharmaceutical
- Morvel Veterinary
- Animix Limited
- What is the 10-year outlook for the global Levamisole Injection market?
- What factors are driving Levamisole Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Levamisole Injection market opportunities vary by end market size?
- How does Levamisole Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Levamisole Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Levamisole Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Levamisole Injection by Country/Region, 2021, 2025 & 2032
2.2 Levamisole Injection Segment by Type
2.2.1 0.05
2.2.2 0.1
2.2.3 Levamisole Injection Sales by Type
2.2.3.1 Global Levamisole Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Levamisole Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Levamisole Injection Sale Price by Type (2021-2026)
2.3 Levamisole Injection Segment by Application
2.3.1 Cattle
2.3.2 Sheep
2.3.3 Goats
2.3.4 Other
2.3.5 Levamisole Injection Sales by Application
2.3.5.1 Global Levamisole Injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Levamisole Injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Levamisole Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Levamisole Injection Breakdown Data by Company
3.1.1 Global Levamisole Injection Annual Sales by Company (2021-2026)
3.1.2 Global Levamisole Injection Sales Market Share by Company (2021-2026)
3.2 Global Levamisole Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Levamisole Injection Revenue by Company (2021-2026)
3.2.2 Global Levamisole Injection Revenue Market Share by Company (2021-2026)
3.3 Global Levamisole Injection Sale Price by Company
3.4 Key Manufacturers Levamisole Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Levamisole Injection Product Location Distribution
3.4.2 Players Levamisole Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LEVAMISOLE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Levamisole Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Levamisole Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Levamisole Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Levamisole Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Levamisole Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Levamisole Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Levamisole Injection Sales Growth
4.4 APAC Levamisole Injection Sales Growth
4.5 Europe Levamisole Injection Sales Growth
4.6 Middle East & Africa Levamisole Injection Sales Growth
5 AMERICAS
5.1 Americas Levamisole Injection Sales by Country
5.1.1 Americas Levamisole Injection Sales by Country (2021-2026)
5.1.2 Americas Levamisole Injection Revenue by Country (2021-2026)
5.2 Americas Levamisole Injection Sales by Type (2021-2026)
5.3 Americas Levamisole Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Levamisole Injection Sales by Region
6.1.1 APAC Levamisole Injection Sales by Region (2021-2026)
6.1.2 APAC Levamisole Injection Revenue by Region (2021-2026)
6.2 APAC Levamisole Injection Sales by Type (2021-2026)
6.3 APAC Levamisole Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Levamisole Injection by Country
7.1.1 Europe Levamisole Injection Sales by Country (2021-2026)
7.1.2 Europe Levamisole Injection Revenue by Country (2021-2026)
7.2 Europe Levamisole Injection Sales by Type (2021-2026)
7.3 Europe Levamisole Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Levamisole Injection by Country
8.1.1 Middle East & Africa Levamisole Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Levamisole Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Levamisole Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Levamisole Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Levamisole Injection
10.3 Manufacturing Process Analysis of Levamisole Injection
10.4 Industry Chain Structure of Levamisole Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Levamisole Injection Distributors
11.3 Levamisole Injection Customer
12 WORLD FORECAST REVIEW FOR LEVAMISOLE INJECTION BY GEOGRAPHIC REGION
12.1 Global Levamisole Injection Market Size Forecast by Region
12.1.1 Global Levamisole Injection Forecast by Region (2027-2032)
12.1.2 Global Levamisole Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Levamisole Injection Forecast by Type (2027-2032)
12.7 Global Levamisole Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Interchemie
13.1.1 Interchemie Company Information
13.1.2 Interchemie Levamisole Injection Product Portfolios and Specifications
13.1.3 Interchemie Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Interchemie Main Business Overview
13.1.5 Interchemie Latest Developments
13.2 Hebei Hope Harmony Pharmaceutical
13.2.1 Hebei Hope Harmony Pharmaceutical Company Information
13.2.2 Hebei Hope Harmony Pharmaceutical Levamisole Injection Product Portfolios and Specifications
13.2.3 Hebei Hope Harmony Pharmaceutical Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hebei Hope Harmony Pharmaceutical Main Business Overview
13.2.5 Hebei Hope Harmony Pharmaceutical Latest Developments
13.3 AdvaCare Pharma
13.3.1 AdvaCare Pharma Company Information
13.3.2 AdvaCare Pharma Levamisole Injection Product Portfolios and Specifications
13.3.3 AdvaCare Pharma Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AdvaCare Pharma Main Business Overview
13.3.5 AdvaCare Pharma Latest Developments
13.4 Farmacy
13.4.1 Farmacy Company Information
13.4.2 Farmacy Levamisole Injection Product Portfolios and Specifications
13.4.3 Farmacy Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Farmacy Main Business Overview
13.4.5 Farmacy Latest Developments
13.5 Laboratorium Ofichem B.V
13.5.1 Laboratorium Ofichem B.V Company Information
13.5.2 Laboratorium Ofichem B.V Levamisole Injection Product Portfolios and Specifications
13.5.3 Laboratorium Ofichem B.V Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Laboratorium Ofichem B.V Main Business Overview
13.5.5 Laboratorium Ofichem B.V Latest Developments
13.6 Suanfarma
13.6.1 Suanfarma Company Information
13.6.2 Suanfarma Levamisole Injection Product Portfolios and Specifications
13.6.3 Suanfarma Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Suanfarma Main Business Overview
13.6.5 Suanfarma Latest Developments
13.7 Johnson & Johnson Innovative Medicines
13.7.1 Johnson & Johnson Innovative Medicines Company Information
13.7.2 Johnson & Johnson Innovative Medicines Levamisole Injection Product Portfolios and Specifications
13.7.3 Johnson & Johnson Innovative Medicines Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Johnson & Johnson Innovative Medicines Main Business Overview
13.7.5 Johnson & Johnson Innovative Medicines Latest Developments
13.8 Xian Tian Guangyuan Biotech
13.8.1 Xian Tian Guangyuan Biotech Company Information
13.8.2 Xian Tian Guangyuan Biotech Levamisole Injection Product Portfolios and Specifications
13.8.3 Xian Tian Guangyuan Biotech Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Xian Tian Guangyuan Biotech Main Business Overview
13.8.5 Xian Tian Guangyuan Biotech Latest Developments
13.9 Nanjing Pharmaceutical
13.9.1 Nanjing Pharmaceutical Company Information
13.9.2 Nanjing Pharmaceutical Levamisole Injection Product Portfolios and Specifications
13.9.3 Nanjing Pharmaceutical Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Nanjing Pharmaceutical Main Business Overview
13.9.5 Nanjing Pharmaceutical Latest Developments
13.10 Morvel Veterinary
13.10.1 Morvel Veterinary Company Information
13.10.2 Morvel Veterinary Levamisole Injection Product Portfolios and Specifications
13.10.3 Morvel Veterinary Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Morvel Veterinary Main Business Overview
13.10.5 Morvel Veterinary Latest Developments
13.11 Animix Limited
13.11.1 Animix Limited Company Information
13.11.2 Animix Limited Levamisole Injection Product Portfolios and Specifications
13.11.3 Animix Limited Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Animix Limited Main Business Overview
13.11.5 Animix Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Levamisole Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Levamisole Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Levamisole Injection by Country/Region, 2021, 2025 & 2032
2.2 Levamisole Injection Segment by Type
2.2.1 0.05
2.2.2 0.1
2.2.3 Levamisole Injection Sales by Type
2.2.3.1 Global Levamisole Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Levamisole Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Levamisole Injection Sale Price by Type (2021-2026)
2.3 Levamisole Injection Segment by Application
2.3.1 Cattle
2.3.2 Sheep
2.3.3 Goats
2.3.4 Other
2.3.5 Levamisole Injection Sales by Application
2.3.5.1 Global Levamisole Injection Sale Market Share by Application (2021-2026)
2.3.5.2 Global Levamisole Injection Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Levamisole Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Levamisole Injection Breakdown Data by Company
3.1.1 Global Levamisole Injection Annual Sales by Company (2021-2026)
3.1.2 Global Levamisole Injection Sales Market Share by Company (2021-2026)
3.2 Global Levamisole Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Levamisole Injection Revenue by Company (2021-2026)
3.2.2 Global Levamisole Injection Revenue Market Share by Company (2021-2026)
3.3 Global Levamisole Injection Sale Price by Company
3.4 Key Manufacturers Levamisole Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Levamisole Injection Product Location Distribution
3.4.2 Players Levamisole Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LEVAMISOLE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Levamisole Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Levamisole Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Levamisole Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Levamisole Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Levamisole Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Levamisole Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Levamisole Injection Sales Growth
4.4 APAC Levamisole Injection Sales Growth
4.5 Europe Levamisole Injection Sales Growth
4.6 Middle East & Africa Levamisole Injection Sales Growth
5 AMERICAS
5.1 Americas Levamisole Injection Sales by Country
5.1.1 Americas Levamisole Injection Sales by Country (2021-2026)
5.1.2 Americas Levamisole Injection Revenue by Country (2021-2026)
5.2 Americas Levamisole Injection Sales by Type (2021-2026)
5.3 Americas Levamisole Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Levamisole Injection Sales by Region
6.1.1 APAC Levamisole Injection Sales by Region (2021-2026)
6.1.2 APAC Levamisole Injection Revenue by Region (2021-2026)
6.2 APAC Levamisole Injection Sales by Type (2021-2026)
6.3 APAC Levamisole Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Levamisole Injection by Country
7.1.1 Europe Levamisole Injection Sales by Country (2021-2026)
7.1.2 Europe Levamisole Injection Revenue by Country (2021-2026)
7.2 Europe Levamisole Injection Sales by Type (2021-2026)
7.3 Europe Levamisole Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Levamisole Injection by Country
8.1.1 Middle East & Africa Levamisole Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Levamisole Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Levamisole Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Levamisole Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Levamisole Injection
10.3 Manufacturing Process Analysis of Levamisole Injection
10.4 Industry Chain Structure of Levamisole Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Levamisole Injection Distributors
11.3 Levamisole Injection Customer
12 WORLD FORECAST REVIEW FOR LEVAMISOLE INJECTION BY GEOGRAPHIC REGION
12.1 Global Levamisole Injection Market Size Forecast by Region
12.1.1 Global Levamisole Injection Forecast by Region (2027-2032)
12.1.2 Global Levamisole Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Levamisole Injection Forecast by Type (2027-2032)
12.7 Global Levamisole Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Interchemie
13.1.1 Interchemie Company Information
13.1.2 Interchemie Levamisole Injection Product Portfolios and Specifications
13.1.3 Interchemie Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Interchemie Main Business Overview
13.1.5 Interchemie Latest Developments
13.2 Hebei Hope Harmony Pharmaceutical
13.2.1 Hebei Hope Harmony Pharmaceutical Company Information
13.2.2 Hebei Hope Harmony Pharmaceutical Levamisole Injection Product Portfolios and Specifications
13.2.3 Hebei Hope Harmony Pharmaceutical Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hebei Hope Harmony Pharmaceutical Main Business Overview
13.2.5 Hebei Hope Harmony Pharmaceutical Latest Developments
13.3 AdvaCare Pharma
13.3.1 AdvaCare Pharma Company Information
13.3.2 AdvaCare Pharma Levamisole Injection Product Portfolios and Specifications
13.3.3 AdvaCare Pharma Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AdvaCare Pharma Main Business Overview
13.3.5 AdvaCare Pharma Latest Developments
13.4 Farmacy
13.4.1 Farmacy Company Information
13.4.2 Farmacy Levamisole Injection Product Portfolios and Specifications
13.4.3 Farmacy Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Farmacy Main Business Overview
13.4.5 Farmacy Latest Developments
13.5 Laboratorium Ofichem B.V
13.5.1 Laboratorium Ofichem B.V Company Information
13.5.2 Laboratorium Ofichem B.V Levamisole Injection Product Portfolios and Specifications
13.5.3 Laboratorium Ofichem B.V Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Laboratorium Ofichem B.V Main Business Overview
13.5.5 Laboratorium Ofichem B.V Latest Developments
13.6 Suanfarma
13.6.1 Suanfarma Company Information
13.6.2 Suanfarma Levamisole Injection Product Portfolios and Specifications
13.6.3 Suanfarma Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Suanfarma Main Business Overview
13.6.5 Suanfarma Latest Developments
13.7 Johnson & Johnson Innovative Medicines
13.7.1 Johnson & Johnson Innovative Medicines Company Information
13.7.2 Johnson & Johnson Innovative Medicines Levamisole Injection Product Portfolios and Specifications
13.7.3 Johnson & Johnson Innovative Medicines Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Johnson & Johnson Innovative Medicines Main Business Overview
13.7.5 Johnson & Johnson Innovative Medicines Latest Developments
13.8 Xian Tian Guangyuan Biotech
13.8.1 Xian Tian Guangyuan Biotech Company Information
13.8.2 Xian Tian Guangyuan Biotech Levamisole Injection Product Portfolios and Specifications
13.8.3 Xian Tian Guangyuan Biotech Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Xian Tian Guangyuan Biotech Main Business Overview
13.8.5 Xian Tian Guangyuan Biotech Latest Developments
13.9 Nanjing Pharmaceutical
13.9.1 Nanjing Pharmaceutical Company Information
13.9.2 Nanjing Pharmaceutical Levamisole Injection Product Portfolios and Specifications
13.9.3 Nanjing Pharmaceutical Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Nanjing Pharmaceutical Main Business Overview
13.9.5 Nanjing Pharmaceutical Latest Developments
13.10 Morvel Veterinary
13.10.1 Morvel Veterinary Company Information
13.10.2 Morvel Veterinary Levamisole Injection Product Portfolios and Specifications
13.10.3 Morvel Veterinary Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Morvel Veterinary Main Business Overview
13.10.5 Morvel Veterinary Latest Developments
13.11 Animix Limited
13.11.1 Animix Limited Company Information
13.11.2 Animix Limited Levamisole Injection Product Portfolios and Specifications
13.11.3 Animix Limited Levamisole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Animix Limited Main Business Overview
13.11.5 Animix Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Levamisole Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Levamisole Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.05
Table 4. Major Players of 0.1
Table 5. Global Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Levamisole Injection Sales Market Share by Type (2021-2026)
Table 7. Global Levamisole Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Levamisole Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Levamisole Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Levamisole Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Levamisole Injection Sale Market Share by Application (2021-2026)
Table 12. Global Levamisole Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Levamisole Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Levamisole Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Levamisole Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Levamisole Injection Sales Market Share by Company (2021-2026)
Table 17. Global Levamisole Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Levamisole Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Levamisole Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Levamisole Injection Producing Area Distribution and Sales Area
Table 21. Players Levamisole Injection Products Offered
Table 22. Levamisole Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Levamisole Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Levamisole Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Levamisole Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Levamisole Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Levamisole Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Levamisole Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Levamisole Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Levamisole Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Levamisole Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Levamisole Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Levamisole Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Levamisole Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Levamisole Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Levamisole Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Levamisole Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Levamisole Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Levamisole Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Levamisole Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Levamisole Injection
Table 52. Key Market Challenges & Risks of Levamisole Injection
Table 53. Key Industry Trends of Levamisole Injection
Table 54. Levamisole Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Levamisole Injection Distributors List
Table 57. Levamisole Injection Customer List
Table 58. Global Levamisole Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Levamisole Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Levamisole Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Levamisole Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Levamisole Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Levamisole Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Levamisole Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Levamisole Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Levamisole Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Levamisole Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Levamisole Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Levamisole Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Levamisole Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Levamisole Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Interchemie Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Interchemie Levamisole Injection Product Portfolios and Specifications
Table 74. Interchemie Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Interchemie Main Business
Table 76. Interchemie Latest Developments
Table 77. Hebei Hope Harmony Pharmaceutical Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Hebei Hope Harmony Pharmaceutical Levamisole Injection Product Portfolios and Specifications
Table 79. Hebei Hope Harmony Pharmaceutical Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Hebei Hope Harmony Pharmaceutical Main Business
Table 81. Hebei Hope Harmony Pharmaceutical Latest Developments
Table 82. AdvaCare Pharma Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. AdvaCare Pharma Levamisole Injection Product Portfolios and Specifications
Table 84. AdvaCare Pharma Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. AdvaCare Pharma Main Business
Table 86. AdvaCare Pharma Latest Developments
Table 87. Farmacy Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Farmacy Levamisole Injection Product Portfolios and Specifications
Table 89. Farmacy Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Farmacy Main Business
Table 91. Farmacy Latest Developments
Table 92. Laboratorium Ofichem B.V Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Laboratorium Ofichem B.V Levamisole Injection Product Portfolios and Specifications
Table 94. Laboratorium Ofichem B.V Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Laboratorium Ofichem B.V Main Business
Table 96. Laboratorium Ofichem B.V Latest Developments
Table 97. Suanfarma Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Suanfarma Levamisole Injection Product Portfolios and Specifications
Table 99. Suanfarma Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Suanfarma Main Business
Table 101. Suanfarma Latest Developments
Table 102. Johnson & Johnson Innovative Medicines Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson Innovative Medicines Levamisole Injection Product Portfolios and Specifications
Table 104. Johnson & Johnson Innovative Medicines Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Johnson & Johnson Innovative Medicines Main Business
Table 106. Johnson & Johnson Innovative Medicines Latest Developments
Table 107. Xian Tian Guangyuan Biotech Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Xian Tian Guangyuan Biotech Levamisole Injection Product Portfolios and Specifications
Table 109. Xian Tian Guangyuan Biotech Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Xian Tian Guangyuan Biotech Main Business
Table 111. Xian Tian Guangyuan Biotech Latest Developments
Table 112. Nanjing Pharmaceutical Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Nanjing Pharmaceutical Levamisole Injection Product Portfolios and Specifications
Table 114. Nanjing Pharmaceutical Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nanjing Pharmaceutical Main Business
Table 116. Nanjing Pharmaceutical Latest Developments
Table 117. Morvel Veterinary Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Morvel Veterinary Levamisole Injection Product Portfolios and Specifications
Table 119. Morvel Veterinary Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Morvel Veterinary Main Business
Table 121. Morvel Veterinary Latest Developments
Table 122. Animix Limited Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Animix Limited Levamisole Injection Product Portfolios and Specifications
Table 124. Animix Limited Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Animix Limited Main Business
Table 126. Animix Limited Latest Developments
Table 1. Levamisole Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Levamisole Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.05
Table 4. Major Players of 0.1
Table 5. Global Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Levamisole Injection Sales Market Share by Type (2021-2026)
Table 7. Global Levamisole Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Levamisole Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Levamisole Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Levamisole Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Levamisole Injection Sale Market Share by Application (2021-2026)
Table 12. Global Levamisole Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Levamisole Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Levamisole Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Levamisole Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Levamisole Injection Sales Market Share by Company (2021-2026)
Table 17. Global Levamisole Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Levamisole Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Levamisole Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Levamisole Injection Producing Area Distribution and Sales Area
Table 21. Players Levamisole Injection Products Offered
Table 22. Levamisole Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Levamisole Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Levamisole Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Levamisole Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Levamisole Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Levamisole Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Levamisole Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Levamisole Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Levamisole Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Levamisole Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Levamisole Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Levamisole Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Levamisole Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Levamisole Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Levamisole Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Levamisole Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Levamisole Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Levamisole Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Levamisole Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Levamisole Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Levamisole Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Levamisole Injection
Table 52. Key Market Challenges & Risks of Levamisole Injection
Table 53. Key Industry Trends of Levamisole Injection
Table 54. Levamisole Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Levamisole Injection Distributors List
Table 57. Levamisole Injection Customer List
Table 58. Global Levamisole Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Levamisole Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Levamisole Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Levamisole Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Levamisole Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Levamisole Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Levamisole Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Levamisole Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Levamisole Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Levamisole Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Levamisole Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Levamisole Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Levamisole Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Levamisole Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Interchemie Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Interchemie Levamisole Injection Product Portfolios and Specifications
Table 74. Interchemie Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Interchemie Main Business
Table 76. Interchemie Latest Developments
Table 77. Hebei Hope Harmony Pharmaceutical Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Hebei Hope Harmony Pharmaceutical Levamisole Injection Product Portfolios and Specifications
Table 79. Hebei Hope Harmony Pharmaceutical Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Hebei Hope Harmony Pharmaceutical Main Business
Table 81. Hebei Hope Harmony Pharmaceutical Latest Developments
Table 82. AdvaCare Pharma Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. AdvaCare Pharma Levamisole Injection Product Portfolios and Specifications
Table 84. AdvaCare Pharma Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. AdvaCare Pharma Main Business
Table 86. AdvaCare Pharma Latest Developments
Table 87. Farmacy Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Farmacy Levamisole Injection Product Portfolios and Specifications
Table 89. Farmacy Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Farmacy Main Business
Table 91. Farmacy Latest Developments
Table 92. Laboratorium Ofichem B.V Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Laboratorium Ofichem B.V Levamisole Injection Product Portfolios and Specifications
Table 94. Laboratorium Ofichem B.V Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Laboratorium Ofichem B.V Main Business
Table 96. Laboratorium Ofichem B.V Latest Developments
Table 97. Suanfarma Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Suanfarma Levamisole Injection Product Portfolios and Specifications
Table 99. Suanfarma Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Suanfarma Main Business
Table 101. Suanfarma Latest Developments
Table 102. Johnson & Johnson Innovative Medicines Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson Innovative Medicines Levamisole Injection Product Portfolios and Specifications
Table 104. Johnson & Johnson Innovative Medicines Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Johnson & Johnson Innovative Medicines Main Business
Table 106. Johnson & Johnson Innovative Medicines Latest Developments
Table 107. Xian Tian Guangyuan Biotech Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Xian Tian Guangyuan Biotech Levamisole Injection Product Portfolios and Specifications
Table 109. Xian Tian Guangyuan Biotech Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Xian Tian Guangyuan Biotech Main Business
Table 111. Xian Tian Guangyuan Biotech Latest Developments
Table 112. Nanjing Pharmaceutical Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Nanjing Pharmaceutical Levamisole Injection Product Portfolios and Specifications
Table 114. Nanjing Pharmaceutical Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nanjing Pharmaceutical Main Business
Table 116. Nanjing Pharmaceutical Latest Developments
Table 117. Morvel Veterinary Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Morvel Veterinary Levamisole Injection Product Portfolios and Specifications
Table 119. Morvel Veterinary Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Morvel Veterinary Main Business
Table 121. Morvel Veterinary Latest Developments
Table 122. Animix Limited Basic Information, Levamisole Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Animix Limited Levamisole Injection Product Portfolios and Specifications
Table 124. Animix Limited Levamisole Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Animix Limited Main Business
Table 126. Animix Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Levamisole Injection
Figure 2. Levamisole Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Levamisole Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Levamisole Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Levamisole Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Levamisole Injection Sales Market Share by Country/Region (2025)
Figure 10. Levamisole Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.05
Figure 12. Product Picture of 0.1
Figure 13. Global Levamisole Injection Sales Market Share by Type in 2026
Figure 14. Global Levamisole Injection Revenue Market Share by Type (2021-2026)
Figure 15. Levamisole Injection Consumed in Cattle
Figure 16. Global Levamisole Injection Market: Cattle (2021-2026) & (K Units)
Figure 17. Levamisole Injection Consumed in Sheep
Figure 18. Global Levamisole Injection Market: Sheep (2021-2026) & (K Units)
Figure 19. Levamisole Injection Consumed in Goats
Figure 20. Global Levamisole Injection Market: Goats (2021-2026) & (K Units)
Figure 21. Levamisole Injection Consumed in Other
Figure 22. Global Levamisole Injection Market: Other (2021-2026) & (K Units)
Figure 23. Global Levamisole Injection Sale Market Share by Application (2025)
Figure 24. Global Levamisole Injection Revenue Market Share by Application in 2026
Figure 25. Levamisole Injection Sales by Company in 2026 (K Units)
Figure 26. Global Levamisole Injection Sales Market Share by Company in 2026
Figure 27. Levamisole Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Levamisole Injection Revenue Market Share by Company in 2026
Figure 29. Global Levamisole Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Levamisole Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Levamisole Injection Sales 2021-2026 (K Units)
Figure 32. Americas Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Levamisole Injection Sales 2021-2026 (K Units)
Figure 34. APAC Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Levamisole Injection Sales 2021-2026 (K Units)
Figure 36. Europe Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Levamisole Injection Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Levamisole Injection Sales Market Share by Country in 2026
Figure 40. Americas Levamisole Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Levamisole Injection Sales Market Share by Region in 2026
Figure 48. APAC Levamisole Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 51. China Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Levamisole Injection Sales Market Share by Country in 2026
Figure 59. Europe Levamisole Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Levamisole Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Levamisole Injection in 2026
Figure 76. Manufacturing Process Analysis of Levamisole Injection
Figure 77. Industry Chain Structure of Levamisole Injection
Figure 78. Channels of Distribution
Figure 79. Global Levamisole Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Levamisole Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Levamisole Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Levamisole Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Levamisole Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Levamisole Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Levamisole Injection
Figure 2. Levamisole Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Levamisole Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Levamisole Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Levamisole Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Levamisole Injection Sales Market Share by Country/Region (2025)
Figure 10. Levamisole Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.05
Figure 12. Product Picture of 0.1
Figure 13. Global Levamisole Injection Sales Market Share by Type in 2026
Figure 14. Global Levamisole Injection Revenue Market Share by Type (2021-2026)
Figure 15. Levamisole Injection Consumed in Cattle
Figure 16. Global Levamisole Injection Market: Cattle (2021-2026) & (K Units)
Figure 17. Levamisole Injection Consumed in Sheep
Figure 18. Global Levamisole Injection Market: Sheep (2021-2026) & (K Units)
Figure 19. Levamisole Injection Consumed in Goats
Figure 20. Global Levamisole Injection Market: Goats (2021-2026) & (K Units)
Figure 21. Levamisole Injection Consumed in Other
Figure 22. Global Levamisole Injection Market: Other (2021-2026) & (K Units)
Figure 23. Global Levamisole Injection Sale Market Share by Application (2025)
Figure 24. Global Levamisole Injection Revenue Market Share by Application in 2026
Figure 25. Levamisole Injection Sales by Company in 2026 (K Units)
Figure 26. Global Levamisole Injection Sales Market Share by Company in 2026
Figure 27. Levamisole Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Levamisole Injection Revenue Market Share by Company in 2026
Figure 29. Global Levamisole Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Levamisole Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Levamisole Injection Sales 2021-2026 (K Units)
Figure 32. Americas Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Levamisole Injection Sales 2021-2026 (K Units)
Figure 34. APAC Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Levamisole Injection Sales 2021-2026 (K Units)
Figure 36. Europe Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Levamisole Injection Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Levamisole Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Levamisole Injection Sales Market Share by Country in 2026
Figure 40. Americas Levamisole Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Levamisole Injection Sales Market Share by Region in 2026
Figure 48. APAC Levamisole Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 51. China Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Levamisole Injection Sales Market Share by Country in 2026
Figure 59. Europe Levamisole Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Levamisole Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Levamisole Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Levamisole Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Levamisole Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Levamisole Injection in 2026
Figure 76. Manufacturing Process Analysis of Levamisole Injection
Figure 77. Industry Chain Structure of Levamisole Injection
Figure 78. Channels of Distribution
Figure 79. Global Levamisole Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Levamisole Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Levamisole Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Levamisole Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Levamisole Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Levamisole Injection Revenue Market Share Forecast by Application (2027-2032)
